Subscribe
Sign in
Subscribe
Sign in
GlobalData
GlobalData

Beth

Netflix’s sentiments down amidst a resilient battle for subscriber growth

Netflix’s sentiments have been hit due to rising competition from Disney+ and Apple TV+, as well as slow revenue growth, says GlobalData, a leading data and analytics company. GlobalData’s Company Filing Analytics platform, which analyzes and showcases sentiments across companies and sectors by scanning through earning transcripts and filing documents, found that Netflix’s overall sentiment score declined […]
Read more

Coronavirus leads to nosedive in global vehicle sales with lowest January registrations since 2012

Global light vehicle sales figures from the first month of 2020 should make for alarming reading. Just 6.2 million were sold in January, – the lowest monthly figure since January 2012, which saw 5.9 million units sold, according to GlobalData, a leading data and analytics company. Driving the drop in sales was the emergence in December 2019 of the coronavirus (COVID-19) in Wuhan, China. The disease has spread rapidly and has already infected more than 80,000 people and […]
Read more

Global bladder cancer market set to reach $4.0bn by 2028

The bladder cancer market is expected to significantly grow from $733m in 2018 to $4.0bn by 2028 across the seven major markets (7MM*) at a compound annual growth rate (CAGR) of 18.5%, according to GlobalData, a leading data and analytics company. The company’s latest report, ‘Bladder cancer: Opportunity Analysis and Forecast to 2028’, states that the main driver of growth will be the approval and launch of pipeline therapies in multiple treatment […]
Read more

ICT spending in Bahrain to reach US$2.1bn by 2024

IT spending in Bahrain is estimated to grow at a compound annual growth rate (CAGR) of 8.6% from US$1.4bn in 2019 to US$2.1bn in 2024, driven by liberal business policy and advanced infrastructure, says GlobalData, a leading data and analytics company. Energy and BFSI will be the sectors witnessing the fastest growth during the period, […]
Read more

As coronavirus spreads, mitigation may be better strategy than quarantine

The statement from the World Health Organization (WHO) that we are in “uncharted territory” on the coronaries outbreak comes as no surprise as Covid-19 infections are spreading beyond China at an alarming pace, with several clusters of outbreaks being reported in Europe, the Middle East and Asia. Governments should start to consider focusing on mitigation […]
Read more

Rare Disease Day 2020: Orphan drugs face uphill battle in 2020

As patients, clinicians and researchers prepare for Rare Disease Day on February 29 2020, GlobalData’s analysis shows the number of drugs awarded orphan drug designations (ODDs) by both the Food and Drug Administration (FDA) and the European Medicines Agency (EMA) has declined over the last six years, despite the benefits of these designations in speeding […]
Read more

The Geneva Show organisers were slow to face coronavirus reality

Following the news today that next week’s 90th Geneva Motor Show has been cancelled; David Leggett, Automotive Editor at GlobalData, a leading data and analytics company, offers his view: “The public health crisis caused by the COVID-19 outbreak has hit home this week with whole towns quarantined in northern Italy and the first cases confirmed […]
Read more

Northrop Grumman’s OmegA rocket moves step closer to achieving Space Force bid

Following today’s news (Friday 28 February) that Northrop Grumman’s OmegA rocket has completed the second stage of a static fire test; Madeline Wild, Associate Aerospace, Defense and Security Analyst at GlobalData, a leading data and analytics company, offers her view on the implications of this event: “OmegA successfully completing its second stage static fire test […]
Read more

Agile Therapeutics’ Twirla could carve out meaningful share in US contraceptive market

Agile Therapeutics’ Twirla (ethinyl estradiol + levonorgestrel) could have an edge over competitors based on milder side-effects and a potentially safer profile, says GlobalData, a leading data and analytics company. As the largest contraceptives market, the US will experience moderate growth at a compound annual growth rate (CAGR) of 4.8%, reaching $5.2bn total sales by 2027. This market offers several options, including both on-demand and longer-acting approaches, and has […]
Read more

Deal activity in AI space showcased fluctuating trend in 2019

Venture capital (VC) funding and mergers & acquisitions (M&A) activity in the artificial intelligence (AI) space showcased a fluctuating trend across all the quarters in 2019, according to GlobalData, a leading and data analytics company. VC funding and M&A deal activity in the AI space remained inconsistent in both value and volume terms during Q1 2019 – Q4 2019. However, despite the fluctuations, both VC and M&A deal volume showcased an increase in Q4 2019 compared to Q4 2018. In contrast, VC and M&A deal value declined in Q4 2019 compared to Q4 2018. Aurojyoti Bose, Lead Analyst at GlobalData, […]
Read more

US tops cross-border M&A list by value and volume, but lags behind in terms of growth in 2019

The US occupied the top position in terms of outbound and inbound mergers and acquisitions (M&A) deal volume and value in 2019. However, it lagged behind some of the top ten countries, in terms of volume and value growth, in 2019 compared to 2018, according to GlobalData, a leading data and analytics company. M&A Outbound The US witnessed more than 1,500 outbound M&A deals worth US$209bn in 2019. The disclosed deal value increased by 46% in 2019 compared to 2018, while deal volume increased by 8%. Top target destinations (in terms of deal volume) for US outbound transactions were the UK, Canada, Australia, Germany and India. The US was followed by the UK (in volume terms), which registered more than 900 […]
Read more
1 … 68 69 70 71 72 … 93